Aurora Analytica
Aurora Analytica is a pioneering artificial intelligence technology company founded in 2023 and incorporated in 2024, dedicated to advancing global health by optimizing the clinical trial lifecycle. Their mission is to harness AI and advanced analytics to optimize clinical trials, accelerate breakthroughs, and improve global human health outcomes. The Aurora Suite™ is their core tech-driven platform that integrates analytics, data, and AI to enhance trial design, planning, and execution. They target organizations in the Biotech, Pharma, CRO, and academic/research sectors. Key performance benefits demonstrated through published research include up to 200% faster enrollment and 80% time savings. The company emphasizes quality, craftsmanship, cutting-edge technology, and a client-centric approach, aiming to be the leading AI-powered platform transforming clinical research.
Aurora Analytica
Aurora Analytica is a pioneering artificial intelligence technology company founded in 2023 and incorporated in 2024, dedicated to advancing global health by optimizing the clinical trial lifecycle. Their mission is to harness AI and advanced analytics to optimize clinical trials, accelerate breakthroughs, and improve global human health outcomes. The Aurora Suite™ is their core tech-driven platform that integrates analytics, data, and AI to enhance trial design, planning, and execution. They target organizations in the Biotech, Pharma, CRO, and academic/research sectors. Key performance benefits demonstrated through published research include up to 200% faster enrollment and 80% time savings. The company emphasizes quality, craftsmanship, cutting-edge technology, and a client-centric approach, aiming to be the leading AI-powered platform transforming clinical research.